Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.
1996
1.2K+
LTM Revenue $238M
LTM EBITDA $68.5M
$619M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Equasens has a last 12-month revenue of $238M and a last 12-month EBITDA of $68.5M.
In the most recent fiscal year, Equasens achieved revenue of $236M and an EBITDA of $77.0M.
Equasens expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Equasens valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $230M | $236M | XXX | XXX | XXX |
Gross Profit | $144M | $156M | XXX | XXX | XXX |
Gross Margin | 63% | 66% | XXX | XXX | XXX |
EBITDA | $74.1M | $77.0M | XXX | XXX | XXX |
EBITDA Margin | 32% | 33% | XXX | XXX | XXX |
Net Profit | $42.0M | $49.8M | XXX | XXX | XXX |
Net Margin | 18% | 21% | XXX | XXX | XXX |
Net Debt | $33.7M | $35.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Equasens's stock price is EUR 37 (or $40).
Equasens has current market cap of EUR 562M (or $604M), and EV of EUR 577M (or $619M).
See Equasens trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$619M | $604M | XXX | XXX | XXX | XXX | $2.72 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Equasens has market cap of $604M and EV of $619M.
Equasens's trades at 2.6x LTM EV/Revenue multiple, and 9.0x LTM EBITDA.
Analysts estimate Equasens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Equasens and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $619M | XXX | XXX | XXX |
EV/Revenue | 2.6x | XXX | XXX | XXX |
EV/EBITDA | 8.0x | XXX | XXX | XXX |
P/E | 11.9x | XXX | XXX | XXX |
P/E/Growth | 5.1x | XXX | XXX | XXX |
EV/FCF | 14.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEquasens's NTM/LTM revenue growth is 7%
Equasens's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Equasens's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Equasens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Equasens and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 3% | XXX | XXX | XXX | XXX |
EBITDA Margin | 33% | XXX | XXX | XXX | XXX |
EBITDA Growth | 4% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 40% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 43% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Equasens acquired XXX companies to date.
Last acquisition by Equasens was XXXXXXXX, XXXXX XXXXX XXXXXX . Equasens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Equasens founded? | Equasens was founded in 1996. |
Where is Equasens headquartered? | Equasens is headquartered in France. |
How many employees does Equasens have? | As of today, Equasens has 1.2K+ employees. |
Who is the CEO of Equasens? | Equasens's CEO is Mr. Denis Supplisson. |
Is Equasens publicy listed? | Yes, Equasens is a public company listed on PAR. |
What is the stock symbol of Equasens? | Equasens trades under EQS ticker. |
When did Equasens go public? | Equasens went public in 2000. |
Who are competitors of Equasens? | Similar companies to Equasens include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of Equasens? | Equasens's current market cap is $604M |
What is the current revenue of Equasens? | Equasens's last 12-month revenue is $238M. |
What is the current EBITDA of Equasens? | Equasens's last 12-month EBITDA is $68.5M. |
What is the current EV/Revenue multiple of Equasens? | Current revenue multiple of Equasens is 2.6x. |
What is the current EV/EBITDA multiple of Equasens? | Current EBITDA multiple of Equasens is 9.0x. |
What is the current revenue growth of Equasens? | Equasens revenue growth between 2023 and 2024 was 3%. |
Is Equasens profitable? | Yes, Equasens is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.